Clinical Trials Browser

Active not recruiting × Lymphoma, B-Cell, Marginal Zone × tafasitamab × Clear all

NCT04646395 2026-04-06

Study of Acalabrutinib and Tafasitamab in MZL Patients

Phase 2 Active not recruiting

Lymphoma, B-Cell, Marginal Zone

NCT04680052 2025-12-22

InMIND

Phase 3 Active not recruiting

654 enrolled 40 charts 3 FDA

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone